NCCN Medical Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below have no relevant financial relationships with ineligible companies to disclose.

Annette P. Hood, PharmD, BCACP
Kathryn D. Mason, FNP
Meena S. Moran, MD
Sharon Walenga, BS, RT(R)(M)

The faculty listed below have the following relevant financial relationships with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Sonya Bhole, MD
Google LLC: Grant/Research Support

Sarah M. Friedewald, MD
Google LLC: Grant/Research Support
Hologic, Inc.: Consulting Fee

William J. Gradishar, MD
AstraZeneca Pharmaceuticals LP: Honoraria; Scientific Advisor
Biotheranostics: Honoraria; Scientific Advisor
Daiichi-Sankyo Co.: Honoraria; Scientific Advisor
Eli Lilly and Company: Scientific Advisor
ImmunoGen, Inc.: Honoraria; Scientific Advisor
MacroGenics: Scientific Advisor
Puma Biotechnology: Scientific Advisor
Seattle Genetics, Inc.: Scientific Advisor

Allison W. Kurian, MD, MSc
Myriad Genetic Laboratories, Inc.: Grant/Research Support

A. Marilyn Leitch, MD
AstraZeneca Pharmaceuticals LP: Consulting Fee
Puma Biotechnology: Consulting Fee

Maryam B. Lustberg, MD, MPH
AstraZeneca Pharmaceuticals LP: Consulting Fee
Biotheranostics: Consulting Fee
Egetis Therapeutics: Consulting Fee
Novartis Pharmaceuticals Corporation: Consulting Fee 
Pfizer Inc.: Consulting Fee
sanofi-aventis U.S.: Consulting Fee

Hope S. Rugo, MD
AstraZeneca Pharmaceuticals LP: Grant/Research Support 
Ayala Pharmaceuticals: Grant/Research Support
Boehringer Ingelheim GmbH: Grant/Research Support 
Daiichi-Sankyo Co.: Grant/Research Support
Eli Lilly and Company: Grant/Research Support 
Gilead Sciences, Inc.: Grant/Research Support 
MacroGenics: Grant/Research Support
Merck & Co., Inc.: Grant/Research Support
Mylan Inc.: Honoraria
Napo Pharmaceuticals Inc.: Honoraria
Novartis Pharmaceuticals Corporation: Grant/Research Support 
Pfizer Inc.: Grant/Research Support
Polyphor Ltd.: Grant/Research Support 
Puma Biotechnology: Honoraria
Roche Laboratories, Inc.: Grant/Research Support 
Samsung: Honoraria
Seattle Genetics, Inc.: Grant/Research Support
Sermonix Pharmaceuticals: Grant/Research Support

Ami N. Shah, MD
AstraZeneca Pharmaceuticals LP: Honoraria

Karen Lisa Smith, MD, MPH
Pfizer Inc.: Grant/Research Support

NCCN Staff Disclosures

None of the planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.